Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blue vitiligo

R Ivker1, M Goldaber, M R Buchness

  • 1Dermatology Service, Department of Veterans Affairs Medical Center, New York, NY 10010.

Journal of the American Academy of Dermatology
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

A patient with AIDS developed blue skin due to simultaneous vitiligo and hyperpigmentation. This rare "blue vitiligo" resolved with typical vitiligo repigmentation.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nongenital dermatologic disease in HIV-infected women.

Journal of the American Academy of Dermatology·1999
Same author

Alternative medicine and dermatology.

Seminars in cutaneous medicine and surgery·1998
Same author

Aid agencies say worst is over in Afghanistan.

Lancet (London, England)·1998
Same author

Chronic actinic dermatitis associated with human immunodeficiency virus infection.

The British journal of dermatology·1998
Same author

Hypophosphatemic vitamin D-resistant rickets, precocious puberty, and the epidermal nevus syndrome.

Archives of dermatology·1998
Same author

Human monkeypox hits beleaguered Zaire.

Lancet (London, England)·1997
Same journal

Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

Journal of the American Academy of Dermatology·2026
Same journal

Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same journal

Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Immunology
  • Infectious Diseases

Background:

  • Vitiligo is an autoimmune condition causing skin depigmentation.
  • Postinflammatory hyperpigmentation (PIH) results from skin inflammation.
  • Acquired immunodeficiency syndrome (AIDS) impacts the immune system.

Observation:

  • A patient with AIDS presented with simultaneous vitiligo and PIH.
  • The combined conditions caused a striking blue skin discoloration.
  • This phenomenon was termed "blue vitiligo".

Findings:

  • The blue coloration resolved over time.
  • Resolution was associated with follicular repigmentation, characteristic of resolving vitiligo.
  • This represents the first reported case of blue vitiligo.

Implications:

  • Highlights unusual dermatological manifestations in AIDS patients.
  • Suggests potential interactions between vitiligo, PIH, and immune status.
  • Warrants further investigation into the pathogenesis of blue vitiligo.